Related Experiment Video
Updated: Jan 21, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy
Moran Dvela-Levitt1, Maria Kost-Alimova2, Maheswarareddy Emani1
1Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
A novel small molecule, BRD4780, clears toxic Mucin 1 kidney disease (MKD) protein aggregates by targeting the TMED9 receptor. This discovery offers a promising therapeutic strategy for MKD and other proteinopathies.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Toxic proteinopathies result from intracellular misfolded protein accumulation, lacking targeted treatments.
- Mucin 1 kidney disease (MKD) is caused by a MUC1 gene frameshift mutation (MUC1-fs), leading to toxic intracellular accumulation.
- The ATF6 unfolded protein response (UPR) pathway is activated by MUC1-fs accumulation.
Purpose of the Study:
- To identify therapeutic strategies for Mucin 1 kidney disease (MKD).
- To investigate the mechanism of MUC1-fs intracellular accumulation and clearance.
- To explore the role of cargo receptors in misfolded protein trafficking.
Main Methods:
- Screening for small molecules that clear MUC1-fs.
- Utilizing patient-derived cells, knockin mouse models, and kidney organoids.
- Investigating the interaction between BRD4780, MUC1-fs, and the TMED9 cargo receptor.
Main Results:
- BRD4780 effectively clears MUC1-fs from patient cells, mouse kidneys, and organoids.
- MUC1-fs is sequestered in TMED9-containing vesicles within the early secretory pathway.
- BRD4780 binds TMED9, releasing MUC1-fs for lysosomal degradation, mimicking TMED9 deletion effects.
Conclusions:
- BRD4780 is a promising therapeutic lead for Mucin 1 kidney disease (MKD).
- The study reveals a novel mechanism of misfolded protein entrapment by cargo receptors.
- Targeting TMED9 offers a strategy for releasing and degrading misfolded proteins in toxic proteinopathies.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Lysosomes
Positive Regulator Molecules
Lysosomal Hydrolases

